Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $54.00 and last traded at $54.00, with a volume of 100 shares changing hands. The stock had previously closed at $52.83.
Basilea Pharmaceutica Price Performance
The firm’s 50-day moving average is $52.83 and its two-hundred day moving average is $52.54. The company has a debt-to-equity ratio of 5.70, a quick ratio of 3.27 and a current ratio of 4.10.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
See Also
- Five stocks we like better than Basilea Pharmaceutica
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Insider Selling Explained: Can it Inform Your Investing Choices?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
